CENTOGENE NV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CENTOGENE NV and buy or sell other stocks, ETFs, and their options commission-free!About CNTGF
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate.
CEODavid Jiménez
CEODavid Jiménez
Employees493
Employees493
HeadquartersRostock, Mecklenburg-Vorpommern
HeadquartersRostock, Mecklenburg-Vorpommern
Founded2018
Founded2018
Employees493
Employees493
CNTGF Key Statistics
Market cap3.19M
Market cap3.19M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.05K
Average volume1.05K
High today$0.11
High today$0.11
Low today$0.11
Low today$0.11
Open price$0.11
Open price$0.11
Volume6.20K
Volume6.20K
52 Week high$0.705
52 Week high$0.705
52 Week low$0.0003
52 Week low$0.0003
Stock Snapshot
CENTOGENE NV(CNTGF) stock is priced at $0.11, giving the company a market capitalization of 3.19M.
On 2025-12-16, CENTOGENE NV(CNTGF) stock moved within a range of $0.11 to $0.11. With shares now at $0.11, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 6.2K, compared to an average daily volume of 1.05K.
Over the past 52 weeks, CENTOGENE NV(CNTGF) stock has traded between a high of $0.71 and a low of $0.00.
Over the past 52 weeks, CENTOGENE NV(CNTGF) stock has traded between a high of $0.71 and a low of $0.00.
People also own
Based on the portfolios of people who own CNTGF. This list is generated using Robinhood data, and it’s not a recommendation.